R

Cartesian Therapeutics
D

RNAC

8.52500
USD
0.08
(0.89%)
مغلق
حجم التداول
5,899
الربح لكل سهم
-2
العائد الربحي
-
P/E
-6
حجم السوق
221,680,741
المقالات

العنوان: Cartesian Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. The companyleverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function.